Lebrikizumab (anti-IL-13) is an IgG4 humanized monoclonal antibody that specifically binds to interleukin-13 (IL-13) and inhibits its function. Lebrikizumab (anti-IL-13) can be used for the research of asthma. Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
Specifictaions: Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB175900-SCI_d3308148370ce8c72db0978a2a33904f.pdf
- UPC:
- 51201572
- Condition:
- New
- Availability:
- 1 day
- Weight:
- 1.09 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab175900-1mg
- CAS:
- 953400-68-5
- Product Size:
- 1mg